Skip to main content

Table 4 Literature review of mantle cell lymphoma

From: Primary non-Hodgkin lymphoma of the tongue base: the clinicopathology of seven cases and evaluation of HPV and EBV status

NameyearNumber of CasesAge/sexSite of tongueClinical featureCytologic FeaturesStageTreatmentSurvival
Saxman S, et al. [40]1997168/MRight baseMass, acute shortness of breathIICHOP and RTDied after 18 months
Guastafierro S, et al. [17]2008162/Fright halfMass, no symptom mentionedsmall lymphocytes, with slightly irregular
indented nuclei and moderately dispersed chromatin
IEAR-CEOP
Plus
Rituximab maintenance therapy
Free of disease for 4 years and 5 months
Owosho, et al. [27]2014160/FBase of tonguecontaining many
large cells similar to DLBCL
  1. F: female; M: male; CHOP: C-cyclophosphamide H-doxorubicin (hydroxydaunomycin) O-vincristine P- prednisolone; RT: radiation therapy; DLBCL: diffuse large B cell lymphoma; R-CEOP: Rituximab–Cyclophosphamide, Epirubicine, Vincristine, Prednisone; −: not mentioned
  2. Cyclophosphamide, Epirubicine, Vincristine, Prednisone; −: not mentioned